Status:

RECRUITING

HYPERtension Reduction Through WALKing Stairs Versus Brisk Walking

Lead Sponsor:

Karolinska Institutet

Collaborating Sponsors:

Södersjukhuset (Stockholm South General Hospital)

Ersta Cardiology Outpatient Clinic

Conditions:

Metabolic Disease

Cardiovascular Diseases

Eligibility:

All Genders

35+ years

Phase:

NA

Brief Summary

This clinical trial investigates whether incorporating stair walking into daily routines improves physical health in adults at risk of lifestyle-related conditions such as hypertension, type 2 diabete...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Men and women aged 35 years or older with increased cardiometabolic risk, defined by all of the following:
  • Clinically confirmed hypertension, with or without antihypertensive treatment, as documented in the Electronic Health Record (EHR).
  • Overweight or obesity, defined as BMI between 27 and 40.
  • Physically inactive lifestyle, defined as either:
  • Light intensity or inactive category on the Stanford Brief Activity Survey (SBAS), or
  • Light intensity or inactive category in the physical activity section of the Swedish National Board of Health and Welfare Lifestyle Questionnaire.
  • Exclusion Criteria
  • Medical contraindications to physical activity (based on FYSS 2021, p. 182):
  • Severe, symptomatic aortic stenosis
  • Acute pulmonary embolism, myocarditis, pericarditis, or systemic infection (e.g., fever, muscle pain, lymphadenopathy)
  • Suspected or known aortic dissection
  • Severe hypertension (Grade 3: SBP \>180 mmHg or DBP \>110 mmHg), regardless of symptoms
  • Unstable coronary artery disease (including unstable angina, suboptimally treated stable angina, or recent myocardial infarction \<8 weeks)
  • Symptomatic, uncontrolled arrhythmia
  • Symptomatic, uncontrolled heart failure
  • Other exclusion criteria:
  • Implanted pacemaker or ICD
  • Pregnancy
  • Smartphone incompatibility with Fitrockr© app (iOS \<16 or Android OS \<10)
  • Inability to understand Swedish or English
  • Any condition that may interfere with protocol compliance (e.g., severe mental illness or cognitive impairment)
  • Inability to walk stairs

Exclusion

    Key Trial Info

    Start Date :

    November 27 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    May 1 2029

    Estimated Enrollment :

    450 Patients enrolled

    Trial Details

    Trial ID

    NCT06952348

    Start Date

    November 27 2025

    End Date

    May 1 2029

    Last Update

    December 8 2025

    Active Locations (4)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (4 locations)

    1

    Karolinska Universitetssjukhuset Huddinge

    Stockholm, Sweden

    2

    Liljeholmen Primary Care Center

    Stockholm, Sweden

    3

    Södersjukhuset

    Stockholm, Sweden

    4

    Södertälje sjukhus

    Stockholm, Sweden